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ABSTRACT
INTRODUCTION In 2013 all UK surgical specialties, with the exception of head and neck surgery, published outcome data adjusted
for case mix for indicator operations. This paper reports a pilot study to validate a previously published risk adjustment score on
patients from separate UK cancer centres.
METHODS A case note audit was performed of 1,075 patients undergoing 1,218 operations for head and neck squamous cell car-
cinoma under general anaesthesia in 4 surgical centres. A logistic regression equation predicting for all complications, previously
validated internally at sites A–C, was tested on a fourth external validation sample (site D, 172 operations) using receiver operating
characteristic curves, Hosmer–Lemeshow goodness of fit analysis and Brier scores.
RESULTS Thirty-day complication rates varied widely (34–51%) between the centres. The predictive score allowed imperfect risk
adjustment (area under the curve: 0.70), with Hosmer–Lemeshow analysis suggesting good calibration. The Brier score changed
from 0.19 for sites A–C to 0.23 when site D was also included, suggesting poor accuracy overall.
CONCLUSIONS Marked differences in operative risk and patient case mix captured by the risk adjustment score do not explain all
the differences in observed outcomes. Further investigation with different methods is recommended to improve modelling of risk.
Morbidity is common, and usually has a major impact on patient recovery, ward occupancy, hospital finances and patient percep-
tion of quality of care. We hope comparative audit will highlight good performance and challenge underperformance where it
exists.
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National audit of surgical outcomes is well established in the
UK surgical specialties. With the exception of head and neck
oncology surgery, all specialties attempt adjustment for
patient case mix when presenting outcome data. A large
national dataset (>10,000 patient care episodes) based on
data derived from Hospital Episode Statistics (HES) has
recently attempted to address this issue in presenting com-
plication rates for surgical units treating patients for head
and neck cancer.1
In 2013 the American College of Surgeons made an online
benchmarking tool available to clinicians and the public.2
Using coding data of 393 participating hospitals (1.4 million
operations), it produces a calculated risk of 9 complications
based on entry of 22 preoperative patient characteristics.
The development of this tool is an ambitious programme of
audit of case mix adjusted outcomes, allowing health insur-
ance providers to align reimbursements with outcomes con-
sistent with quality care. A secondary benefit is the provision
of information for enhanced patient consent; by adjusting
risk for patient factors, clinicians can produce patient spe-
cific probability data pertaining to complications and mortal-
ity. However, this online score does not as yet allow
calculation of risk based on ablative and reconstructive
aspects of a major head and neck case.
Both in the US and the UK, work towards risk adjusted
audit of outcomes is limited by concerns about the accuracy
of data derived from clinical coders and the application of
imperfect models to individual patient discussions. We
sought to address the need for good quality multicentre audit
data in a previous case note audit of three surgical units
(sites A–C) in the south-east of England, auditing outcomes
of over 1,000 operations, leading to the development of a
pilot logistic regression score of three variables.3 This risk
algorithm requires three data points: World Health Organi-
zation (WHO) performance status, a description of the com-
plexity of surgery (‘minor’, ‘intermediate’ or ‘major’; derived
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from the Bupa classification of operative severity) and an
estimation of intraoperative blood loss.
The risk model was validated internally, and demon-
strated good calibration and reasonable discrimination for
the purposes of case mix adjustment.3 The present study
applied the logistic regression model to a fourth treatment
unit (site D) as a validation of its accuracy and utility.
Methods
A case note audit of a two-year period (June 2013 –
June 2015) was undertaken by the lead author at site D. Data
collection was retrospective for the first half of this period
but prospective for the second half. Complications were
recorded according to the Clavien–Dindo classification
(Fig 1).4 Predicted morbidity values were derived for each
patient care episode using the previously published algo-
rithm.3 Data pertaining to patient demographics, indices of
functional status, tumour stage, and operative and anaes-
thetic treatment were also included in the audit for the pur-
pose of further model development. The Waterlow score,
which has been shown to be useful as a means of predicting
postoperative morbidity,5 was tested for consideration of
incorporation in a future scoring system.
Statistical analysis
Calibration, discrimination and accuracy of the risk model
were examined in the form of receiver operating character-
istic curves, Hosmer–Lemeshow analysis and Brier scores.
Excel® (Microsoft, Redmond, WA, US) was used to generate
Brier scores while MedCalc® version 16.2 (MedCalc Soft-
ware, Mariakerke, Belgium) was used for the remaining
analyses (chi-squared tests for categorical data, analysis of
variance [ANOVA] and Kruskal–Wallis tests for continuous
data).
Complication grade Definition
Grade 1
Any deviation from the expected
post operative course that does not require
specific treatment
Complications requiring drug therapy, bllod
transfusion or nutritional support
Postoperative changes that require invasive
treatment (puncture, drainage and re-
operations)
Complications with imminent risk of death
and need for intensive care
Postoperative death
Grade 2
Grade 3
Grade 4
Grade 5
Figure 1 Clavien–Dindo classification of surgical
complications4
Table 1 Comparison of patient data by hospital site
Site A (n=180) Site B (n=234) Site C (n=616) Site D (n=188) Total (n=1,218) 2 p-value
Age F-ratio 9.96 <0.001
Mean age 65.7 66.6 61.8 66.2
95% CI 62.9–67.3 64.4–68.2 60.1–62.6 64.5–68.6
Range 23–93 35–100 22–93 27–96
Sex 14 0.003
Male 119 (66.1%) 170 (72.6%) 370 (60.1%) 130 (72.6%) 789 (64.8%)
Female 61 (33.9%) 64 (27.4%) 246 (39.9%) 58 (27.4%) 429 (35.2%)
WHO performance
status
347 <0.00001
0 29 (16.1%) 16 (6.8%) 399 (64.8%) 110 (58.5%) 554 (45.5%)
1 105 (58.3%) 139 (59.4%) 141 (22.9%) 36 (19.1%) 421 (34.6%)
2 30 (16.7%) 61 (26.1%) 42 (6.8%) 24 (12.8%) 157 (12.9%)
3 8 (4.4%) 14 (6.0%) 16 (2.6%) 18 (9.6%) 56 (4.6%)
4 0 (0%) 1 (0.4%) 0 (0%) 0 (0%) 1 (0.1%)
Data missing 8 (4.4%) 3 (1.3%) 18 (2.9%) 0 (0%) 29 (2.4%)
Scale of surgery 158 <0.0001
Minor (<1h) 51 (28.3%) 48 (20.5%) 90 (14.6%) 29 (15.4%) 218 (17.9%)
Intermediate 73 (40.6%) 110 (47.0%) 174 (28.2%) 36 (19.1%) 393 (32.3%)
Major (>6h +/- flap) 53 (29.4%) 76 (32.5%) 268 (43.5%) 123 (65.4%) 520 (42.7%)
Data missing 3 (1.7%) 0 (0%) 84 (13.6%) 0 (0%) 87 (7.1%)
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Alcohol consumption 190 <0.00001
No alcohol 78 (43.3%) 97 (41.5%) 67 (10.9%) 60 (31.9%) 302 (24.8%)
Light 37 (20.6%) 65 (27.8%) 236 (38.3%) 55 (29.3%) 393 (32.3%)
Moderate 7 (3.9%) 17 (7.3%) 88 (14.3%) 39 (20.7%) 151 (12.4%)
Heavy 35 (19.4%) 36 (15.4%) 121 (19.6%) 21 (11.2%) 213 (17.5%)
Ex-heavy 5 (2.8%) 14 (6.0%) 61 (9.9%) 13 (6.9%) 93 (7.6%)
Data missing 18 (10.0%) 5 (2.1%) 43 (7.0%) 0 (0%) 66 (5.4%)
Smoking history 36 <0.0001
Never smoked 63 (35.0%) 96 (41.0%) 138 (22.4%) 69 (36.7%) 366 (30.0%)
Smoker/ex-smoker 100 (55.6%) 134 (57.3%) 447 (72.6%) 119 (63.3%) 800 (65.7%)
Data missing 17 (9.4%) 4 (1.7%) 31 (5.0%) 0 (0%) 52 (4.3%)
ACE-27 score 358 <0.0001
0 73 (40.6%) 7 (3.0%) 279 (45.3%) 40 (21.3%) 399 (32.8%)
1 64 (35.6%) 148 (63.2%) 215 (34.9%) 105 (55.9%) 532 (43.7%)
2 36 (20.0%) 73 (31.2%) 48 (7.8%) 36 (19.1%) 193 (15.8%)
3 1 (0.6%) 5 (2.1%) 3 (0.5%) 7 (3.7%) 16 (1.3%)
Data missing 6 (3.3%) 1 (0.4%) 71 (11.5%) 0 (0%) 78 (6.4%)
MUST score 948 <0.0001
0 56 (31.1%) 168 (71.8%) 0 (0%) 151 (80.3%) 375 (30.8%)
1 7 (3.9%) 16 (6.8%) 0 (0%) 12 (6.4%) 35 (2.9%)
2 2 (1.1%) 16 (6.8%) 0 (0%) 12 (6.4%) 30 (2.5%)
3 0 (0%) 5 (2.1%) 0 (0%) 6 (3.2%) 11 (0.9%)
4 0 (0%) 0 (0%) 0 (0%) 3 (1.6%) 3 (0.2%)
5 0 (0%) 0 (0%) 0 (0%) 2 (1.1%) 2 (0.2%)
Data missing 115 (63.9%) 29 (12.4%) 616 (100%) 2 (1.1%) 762 (62.6%)
T stage 125 <0.0001
0/x 30 (16.7%) 61 (26.1%) 38 (6.2%) 36 (19.1%) 165 (13.5%)
1 69 (38.3%) 62 (26.5%) 164 (26.6%) 38 (20.2%) 333 (27.3%)
2 33 (18.3%) 38 (16.2%) 175 (28.4%) 35 (18.6%) 281 (23.1%)
3 9 (5.0%) 14 (6.0%) 82 (13.3%) 10 (5.3%) 115 (9.4%)
4 32 (17.8%) 53 (22.6%) 131 (21.3%) 67 (35.6%) 283 (23.2%)
Data missing 7 (3.9%) 6 (2.6%) 26 (4.2%) 2 (1.1%) 41 (3.4%)
N stage 71 <0.0001
0/x 97 (53.9%) 127 (54.3%) 386 (62.7%) 105 (55.9%) 715 (58.7%)
1 24 (13.3%) 29 (12.4%) 108 (17.5%) 20 (10.6%) 181 (14.9%)
2a 15 (8.3%) 17 (7.3%) 31 (5.0%) 6 (3.2%) 69 (5.7%)
2b 29 (16.1%) 33 (14.1%) 29 (4.7%) 40 (21.3%) 131 (10.8%)
2c 6 (3.3%) 10 (4.3%) 16 (2.6%) 9 (4.8%) 41 (3.4%)
3 3 (1.7%) 7 (3.0%) 17 (2.8%) 5 (2.7%) 32 (2.6%)
Data missing 6 (3.3%) 11 (4.7%) 29 (4.7%) 3 (1.6%) 49 (4.0%)
ACE = Adult Co-morbidity Evaluation; CI = confidence interval; MUST = Malnutrition Universal Screening Tool;
WHO = World Health Organization
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Results
During the study period, 172 consecutive patients received
185 curative operations for head and neck squamous cell
carcinoma at site D. Thirteen of these had recurrent disease.
When added to the datasets for sites A–C, this totalled 1,075
patients receiving 1,218 operations. Of these, 96 patients had
missing demographic data or were lacking recorded out-
comes. The majority (n=83) of these cases were from the
historical cohort. This left 979 complete patient care epi-
sodes for the later part of the analysis (model development).
Case mix and surgical management was heterogeneous for
all criteria (p<0.05) (Table 1). Across all four sites, 218
operations (18%) were classified as minor, 393 (32%) as
intermediate and 520 (43%) as major operations.
For the 979 patient care episodes analysed, postoperative
complications within 30 days were frequent overall (43%)
and the raw complication rates differed significantly
between sites. Site A had the fewest complications (35%)
and site D had the most (51%) (2=10.3, p=0.016). Overall,
wound complications, namely dehiscence and infections
(5.6% and 4.3% respectively), and pneumonia (4.9%) were
the most common (Table 2). Complete flap failure rates
were similar across the sites (site A: 2/160 [1.3%], site B: 3/
208 [1.4%], site C: 10/439 [2.3%], site D: 8/172 [4.7%]; 2=4.4,
p=0.21) but severe complications (Clavien–Dindo grade ≥III)
Table 2 Complications by hospital site
Complications Site A (n=160) Site B (n=208) Site C (n=439) Site D (n=172) Total(n=979)
Wound
Loss of flap 2 (1.3%) 3 (1.4%) 10 (2.3%) 8 (4.7%) 23 (2.3%)
Partial loss of flap 0 (0%) 0 (0%) 8 (1.8%) 2 (1.2%) 10 (1.0%)
Wound dehiscence 11 (6.9%) 8 (3.8%) 21 (4.8%) 15 (8.7%) 55 (5.6%)
Wound infection 9 (5.6%) 7 (3.8%) 8 (1.8%) 18 (10.5%) 42 (4.3%)
Haematoma 4 (2.5%) 4 (1.9%) 9 (2.1%) 11 (6.4%) 28 (2.9%)
Orocutaneous fistula 1 (0.6%) 0 (0%) 6 (1.4%) 4 (2.3%) 11 (1.1%)
Chyle leak 1 (0.6%) 3 (1.4%) 3 (0.7%) 2 (1.2%) 9 (0.9%)
Neck abscess 0 (0%) 0 (0%) 3 (0.7%) 0 (0%) 3 (0.3%)
Cardiovascular
Atrial fibrillation 2 (1.3%) 4 (1.9%) 5 (1.1%) 5 (2.9%) 16 (1.6%)
Cardiac arrest 1 (0.6%) 2 (1.0%) 5 (1.1%) 0 (0%) 8 (0.8%)
Myocardial infarction 0 (0%) 2 (1.0%) 3 (0.7%) 2 (1.2%) 7 (0.7%)
Congestive cardiac failure 2 (1.3%) 1 (0.5%) 1 (0.2%) 2 (1.2%) 6 (0.6%)
Carotid blowout 1 (0.6%) 0 (0%) 1 (0.2%) 1 (0.6%) 3 (0.3%)
Respiratory
Pneumonia 8 (5.0%) 10 (4.8%) 19 (4.3%) 11 (6.4%) 48 (4.9%)
Pneumothorax 2 (1.3%) 1 (0.5%) 1 (0.2%) 0 (0%) 4 (0.4%)
Pulmonary embolism 0 (0%) 1 (0.5%) 1 (0.2%) 0 (0%) 2 (0.2%)
Unspecified respiratory failure 0 (0%) 0 (0%) 4 (0.9%) 0 (0%) 4 (0.4%)
Gastrointestinal
Upper gastrointestinal bleed 2 (1.3%) 1 (0.5%) 0 (0%) 0 (0%) 3 (0.3%)
Pancreatitis 1 (0.6%) 0 (0%) 1 (0.2%) 1 (0.6%) 3 (0.3%)
Genitourinary
Urinary retention 0 (0%) 4 (1.9%) 4 (0.9%) 1 (0.6%) 9 (0.9%)
Other
Delirium 1 (0.6%) 0 (0%) 0 (0%) 1 (0.6%) 2 (0.2%)
Mortality
30-day mortality 3 (1.9%) 3 (1.4%) 11 (2.5%) 1 (0.6%) 18 (1.8%)
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varied significantly (site A: 10/160 [6.3%], site B: 19/208
[9.1%], site C: 48/439 [10.9%], site D: 48/172 [27.9%];
2=47.7, p<0.0001). The 30-day mortality rate was similar at
0.6–2.5% (2=2.7, p=0.42).
No length of hospital stay (LOS) data were available for
site C, and date of discharge was missing for some patients
at sites A and B. LOS data for site D, however, were com-
plete. For sites A, B and D, there was little difference in LOS
for procedures of minor and intermediate complexity
(Table 3). For major operations, however, the mean LOS
varied between the sites (site A: 24 days, site B: 27 days,
site D: 15 days; p<0.0001).
Risk adjustment algorithm
The data for each site were analysed to compare the mean
rates of observed complications against the spread of
predicted probabilities of complications (Fig 2). For site D,
the logistic regression score suggested an expected compli-
cation rate (adjusted for case mix) of 47% while the
observed complication rate was 51%. Good calibration was
confirmed with the Hosmer–Lemeshow test, which found no
significant difference between predicted and observed com-
plication rates for groups divided into deciles of risk
(2=6.514, df=7, p=0.48) (Table 4). The receiver operating
characteristic curve (area under the curve [AUC]: 0.70) indi-
cated that discrimination was poor to reasonable (Fig 3) and
the Brier score was unacceptably high (0.35), implying poor
accuracy.
The risk adjustment algorithm allowed relative morbidity
rates for the four sites to be compared in the form of a funnel
plot (Fig 4). All units were performing within the 95%
bounds of expected morbidity rates. The Waterlow score
Table 3 Length of stay data by scale of surgery
Scale of surgery Length of stay (days)
Site A Site B Site D
n Mean 95% CI Median n Mean 95% CI Median n Mean 95% CI Median
Minor (<1h) 45 1.4 1.0–1.7 1.0 40 2.6 1.0–4.2 1.0 27 2.6 1.0–4.1 1.0
Intermediate 54 7.0 1.7–12.2 3.0 82 7.6 5.2–10.0 4.0 31 4.6 3.8–5.4 4.0
Major (>6h +/- flap) 35 24.6 17.7–31.5 18.0 64 26.7 20.0–33.5 16.5 114 14.8 12.5–17.1 12.0
CI = confidence interval
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Figure 2 Box and whisker plot comparing the observed mean postoperative complication rates against the spread of predicted
probabilities of complications
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was tested as an additional predictor variable in the risk
model. It correlated positively with adverse outcome
(ANOVA, p=0.08), suggesting potential utility in the model.
Discussion
Given the heterogeneity of patient cohorts across different
sites, in order to meaningfully compare surgical perform-
ance, it is essential to attempt to adjust for risk. Conse-
quently, benchmarking surgical performance in other
specialties has been characterised by the development of
risk models such as the EuroScore,6 the POSSUM
(Physiological and Operative Severity Score for the enUmer-
ation of Mortality and morbidity)7 and Glasgow aneurysm
score.8 In the UK, no such risk adjustment is implemented
systemically in comparing the incidence of postoperative
complications in head and neck oncology.
The need to pursue risk adjustment is seen in the paradox
of complications and observed LOS data. Observed morbid-
ity rates varied between the units (35–51%) but premorbid
patient and tumour characteristics also varied significantly.
Site D had the shortest mean LOS for patients undergoing
major surgery (15 days) despite its cohort having higher fre-
quencies of increased WHO performance status and micro-
vascular reconstructions (Table 1). The site D complication
rate was in keeping with the predicted probabilities of post-
operative complications. Furthermore, using the risk algo-
rithm, the morbidity rates for the different sites can be
compared meaningfully on a funnel plot, which demon-
strates risk adjusted performance within the 95% bounds of
expected morbidity rates for all four sites (Fig 4).
Although Site D had the highest frequency of complica-
tions (51%), the 30-day mortality rate (0.6%) was lower than
for the other sites. However, as death was a rare event, stat-
istical significance for this finding is uncertain. Clavien–
Dindo grades III and IV denote severe surgical or medical
morbidity (Fig 1). Such complications were also seen more
frequently in patients at site D.
Interpreting the paradox of more complications and
shorter LOS requires risk adjustment as well as an assess-
ment of possible differences in service provision. We believe
that an increased level of involvement of senior anaesthetic
staff, supporting the surgical team, allowed prompt recogni-
tion of clinical deterioration and a lower threshold for
patient transfer to a high dependency unit (HDU), where
complications are managed aggressively, and that this led to
a significant reduction in LOS. More information about LOS
in the HDU setting and comparison of staffing reviews
recorded in the case notes around the time of deterioration
is needed to test this assertion.
Table 4 Hosmer–Lemeshow goodness of fit for site D
Morbidity Complications No complications
Risk band Observed Expected (O-E)^2/E Ratio Observed Expected (O-E)^2/E
0–9% (n=14) 2 1.3 0.43 0.34 12 12.7 0.04
10–19% (n=13) 3 2.1 0.44 0.21 10 10.9 0.08
20–29% (n=17) 4 4.4 0.04 0.01 13 12.6 0.01
30–39% (n=10) 3 3.5 0.06 0.02 7 6.6 0.03
40–49% (n=4) 2 1.7 0.04 0.02 2 2.3 0.03
50–59% (n=52) 35 27.6 2.01 0.07 17 24.4 2.26
60–69% (n=49) 32 31.3 0.02 0.00 17 17.7 0.03
70–79% (n=10) 6 7.4 0.26 0.03 4 2.6 0.73
Total (n=169)* 87 (51%) 79.1 (47%) 0.78 0.01 82 89.9 0.69
*3 cases excluded because blood loss data were missing and risk score was not calculated
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Figure 3 Receiver operating characteristic curve for site D
data with 95% confidence interval
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Another untested assertion is that delayed discharge sec-
ondary to lack of family support and/or social services provi-
sion is conspicuous in its absence at site D. The catchment
area covered by this hospital is larger than for the other
sites. We speculate that the increased distance families must
travel to visit the patient makes the social network more
‘willing’ to receive the patient back to the home setting
when medically fit for discharge.
Case note audit of outcomes has been suggested as the
gold standard for collecting data for the purposes of mor-
bidity and mortality benchmarking. Ideally, internal verifi-
cation of data accuracy would have strengthened the
perceived integrity of the data. HES is an alternative source
of data but the authors of a paper on the largest series of
UK head and neck patients using HES data concede that
over half of care episodes contain details that do not reflect
data held by the multidisciplinary team and that complica-
tions are significantly underreported with the existing cod-
ing framework.9
Logistic regression analysis is a traditional statistical mul-
tivariate classifier technique that manages categorical, ordi-
nal and continuous data well. The score algorithm in this
study had internal validation (sites A–C), confirmed by an
AUC of 0.76,3 but for the external validation dataset (site D),
discrimination worsened (AUC: 0.70), suggesting overfitting
of the original model or a genuine increase in morbidity that
was adjusted for inadequately by the current model. Modifi-
cation of the score with more parameters that correlate with
perioperative risk should bring further improvement.
To this end, our study also investigated the Waterlow
score as a potential additional predictor variable for the
logistic regression model. A high preoperative Waterlow
score has previously been found to be associated with
increased postoperative morbidity.5 In terms of its utility for
the risk algorithm, the Waterlow score looks promising as it
appears to correlate with risk on initial testing. However,
some discrimination will be lost through surgical case selec-
tion. As with the WHO performance status, if patients are
very frail, they are less likely to be offered radical surgery.
Patients with a performance status of 3 or 4 accounted for
less than 5% of our cohort. Much bigger datasets are there-
fore required to capture those few who do have an operation
in order to allow effective enumeration of added risk for the
purposes of improved score discrimination.
Further effort is necessary to acquire new validation data-
sets in order to refine the algorithm before one can focus on
the comparatively high morbidity rates at site D because the
discriminatory power is not adequate (AUC: 0.70). Different
forecasting classifier methods such as Bayesian models,
decision trees or artificial neural networks should be tested
as they have some pedigree in clinical contexts, especially in
diagnostics and outcome prediction.10 This will be the sub-
ject of a further publication.
Conclusions
Multicentre audit of early outcomes in head and neck sur-
gery is in its infancy still. This validation study of a new case
mix adjustment algorithm suggests further development is
required and that quality of care cannot be distilled as a sur-
gical (or surgeon) issue. Data mining techniques may yield
improvement in score performance; Bayesian models, deci-
sion trees and artificial neural networks merit investigation
although specialist knowledge is a prerequisite. Early mor-
bidity after head and neck surgery is frequent, and contrib-
utes to mortality in around 1–2% of patients. Morbidity
increases psychosocial distress, hospital bed occupancy
rates and healthcare costs, and needs to be minimised
where possible by highlighting and spreading good institu-
tional practices.
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Figure 4 Funnel plot comparing frequency of complications between the four sites
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